Market Cap (In JPY)
3.3 Billion
Revenue (In JPY)
-
Net Income (In JPY)
-1.02 Billion
Avg. Volume
2.5 Million
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 60.0-123.0
- PE
- -
- EPS
- -
- Beta Value
- 0.602
- ISIN
- JP3974850004
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Yoshikazu Nakamura Ph.D.
- Employee Count
- -
- Website
- https://www.ribomic.com
- Ipo Date
- 2014-09-25
- Details
- Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. Ribomic Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan.
More Stocks
-
4924
-
HTJHTC Corporation
HTJ
-
CHEMCON
-
8929
-
BPCL
-
1527Basso Industry Corp.
1527
-
HUMAWHumacyte, Inc.
HUMAW
-
SEDANASedana Medical AB (publ)
SEDANA